Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7279)
All Articles published online
|
Oct 31, 2009 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kreidl E, Öztürk D, Metzner T, Berger W, Grusch M. Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol 2009; 1(1): 17-27 [PMID: 21160961 DOI: 10.4254/wjh.v1.i1.17] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v1/i1/17.htm |
| Number | Citing Articles |
| 1 |
Ousseynou Sarr, Katherine E. Mathers, Christina Vanderboor, Kristina Wiggers, Aditya Devgan, Daniel B. Hardy, Lin Zhao, Timothy R. H. Regnault. Sex-specific alterations in hepatic cholesterol metabolism in low birth weight adult guinea pigs. Pediatric Research 2022; 91(5): 1078 doi: 10.1038/s41390-021-01491-w
|
| 2 |
C. Fournier, R. Rizzoli, K. Bouzakri, P. Ammann. Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga. Osteoporosis International 2016; 27(11): 3365 doi: 10.1007/s00198-016-3666-8
|
| 3 |
Emine Sahin, Julia Münzker, Michael Grusch. Encyclopedia of Cancer. 2014; : 1772 doi: 10.1007/978-3-662-46875-3_7169
|
| 4 |
Dorota Skrzypczak, Marzena Skrzypczak-Zielińska, Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Piotr Eder, Ryszard Słomski, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak. Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines 2021; 9(10): 1301 doi: 10.3390/biomedicines9101301
|
| 5 |
Fen-Yu Tseng, Yen-Ting Chen, Yu-Chao Chi, Pei-Lung Chen, Wei-Shiung Yang. Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism. Medicine 2016; 95(5): e2661 doi: 10.1097/MD.0000000000002661
|
| 6 |
Shifeng Su, Amanda B. Parris, Gail Grossman, James L. Mohler, Zengjun Wang, Elizabeth M. Wilson. Up‐Regulation of Follistatin‐Like 1 By the Androgen Receptor and Melanoma Antigen‐A11 in Prostate Cancer. The Prostate 2017; 77(5): 505 doi: 10.1002/pros.23288
|
| 7 |
Silvia Iori, Caterina D'Onofrio, Nihay Laham-Karam, Isidore Mushimiyimana, Lorena Lucatello, Ludovica Montanucci, Rosa Maria Lopparelli, Federico Bonsembiante, Francesca Capolongo, Marianna Pauletto, Mauro Dacasto, Mery Giantin. Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12). Biochemical Pharmacology 2024; 224: 116231 doi: 10.1016/j.bcp.2024.116231
|
| 8 |
Stergios A. Polyzos, Jannis Kountouras, Athanasios D. Anastasilakis, Georgios Α. Triantafyllou, Christos S. Mantzoros. Activin A and follistatin in patients with nonalcoholic fatty liver disease. Metabolism 2016; 65(10): 1550 doi: 10.1016/j.metabol.2016.07.009
|
| 9 |
Hongjun Zhang, Baoling Ju, Ying Nie, Baohui Song, Yuanhong Xu, Ping Gao. Adenovirus‑mediated knockdown of activin A receptor type�2A attenuates immune‑induced hepatic fibrosis in mice and inhibits interleukin‑17‑induced activation of primary hepatic stellate cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3600
|
| 10 |
Wei Song, Daojun Cheng, Shangyu Hong, Benoit Sappe, Yanhui Hu, Neil Wei, Changqi Zhu, Michael B. O’Connor, Pavlos Pissios, Norbert Perrimon. Midgut-Derived Activin Regulates Glucagon-like Action in the Fat Body and Glycemic Control. Cell Metabolism 2017; 25(2): 386 doi: 10.1016/j.cmet.2017.01.002
|
| 11 |
Ruochen Du, Liqi Wen, Min Niu, Liting Zhao, Xiaoya Guan, Jiao Yang, Chunming Zhang, Hongliang Liu. Activin receptors in human cancer: Functions, mechanisms, and potential clinical applications. Biochemical Pharmacology 2024; 222: 116061 doi: 10.1016/j.bcp.2024.116061
|
| 12 |
Hongjun Zhang, Baoling Ju, Xiaoli Zhang, Yanfei Zhu, Ying Nie, Yuanhong Xu, Qiuxia Lei. Magnolol Attenuates Concanavalin A‐induced Hepatic Fibrosis, Inhibits CD4+ T Helper 17 (Th17) Cell Differentiation and Suppresses Hepatic Stellate Cell Activation: Blockade of Smad3/Smad4 Signalling. Basic & Clinical Pharmacology & Toxicology 2017; 120(6): 560 doi: 10.1111/bcpt.12749
|
| 13 |
Michele Vacca, Jack Leslie, Samuel Virtue, Brian Y. H. Lam, Olivier Govaere, Dina Tiniakos, Sophie Snow, Susan Davies, Kasparas Petkevicius, Zhen Tong, Vivian Peirce, Mette Juul Nielsen, Zsuzsanna Ament, Wei Li, Tomasz Kostrzewski, Diana Julie Leeming, Vlad Ratziu, Michael E. D. Allison, Quentin M. Anstee, Julian L. Griffin, Fiona Oakley, Antonio Vidal-Puig. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nature Metabolism 2020; 2(6): 514 doi: 10.1038/s42255-020-0214-9
|
| 14 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 2022; 123(10): 1553 doi: 10.1002/jcb.30252
|
| 15 |
Matthew Hamang, Benjamin Yaden, Guoli Dai. Gastrointestinal pharmacology activins in liver health and disease. Biochemical Pharmacology 2023; 214: 115668 doi: 10.1016/j.bcp.2023.115668
|
| 16 |
Petra Džepina, Marijana Ćorić, Matea Kovačić Perica, Mirna Natalija Aničić, Ruža Grizelj, Jurica Vuković. Expression of activin A in liver tissue and the outcome of patients with biliary atresia. Frontiers in Pediatrics 2024; 12 doi: 10.3389/fped.2024.1457837
|
| 17 |
Dimitry A. Chistiakov, Pavel A. Chistiakov. Strategies to produce hepatocytes and hepatocyte‐like cells from pluripotent stem cells. Hepatology Research 2012; 42(2): 111 doi: 10.1111/j.1872-034X.2011.00896.x
|
| 18 |
Olga K. Parfenova, Vladimir G. Kukes, Dmitry V. Grishin. Follistatin-Like Proteins: Structure, Functions and Biomedical Importance. Biomedicines 2021; 9(8): 999 doi: 10.3390/biomedicines9080999
|
| 19 |
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Limin Chen. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated‐Interferon‐α Based Therapy. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/287640
|
| 20 |
Salima Aroua, Gersende Maugars, Shan-Ru Jeng, Ching-Fong Chang, Finn-Arne Weltzien, Karine Rousseau, Sylvie Dufour. Pituitary gonadotropins FSH and LH are oppositely regulated by the activin/follistatin system in a basal teleost, the eel. General and Comparative Endocrinology 2012; 175(1): 82 doi: 10.1016/j.ygcen.2011.10.002
|
| 21 |
Blanca Herrera, Annalisa Addante, Aránzazu Sánchez. BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration. International Journal of Molecular Sciences 2017; 19(1): 39 doi: 10.3390/ijms19010039
|
| 22 |
Xiao-Wei Zhang, Ji-Chao Zhou, Dian Peng, Fang Hua, Ke Li, Jiao-Jiao Yu, Xiao-Xi Lv, Bing Cui, Shan-Shan Liu, Jin-Mei Yu, Feng Wang, Cai-Cai Jin, Zhao-Na Yang, Chen-Xi Zhao, Xue-Ying Hou, Bo Huang, Zhuo-Wei Hu. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy 2020; 16(5): 782 doi: 10.1080/15548627.2019.1635383
|
| 23 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_172-1
|
| 24 |
Aristeidis H. Katsanos, Kalliroi Kyriakidi, Fotini B. Karassa, Dimitrios Politis, Alexandros Skamnelos, Dimitrios K. Christodoulou, Konstantinos H. Katsanos. Biomarkers for Endometriosis. 2017; : 41 doi: 10.1007/978-3-319-59856-7_3
|
| 25 |
Dongshunyi Li, Jeremy J. Velazquez, Jun Ding, Joshua Hislop, Mo R. Ebrahimkhani, Ziv Bar-Joseph. TraSig: inferring cell-cell interactions from pseudotime ordering of scRNA-Seq data. Genome Biology 2022; 23(1) doi: 10.1186/s13059-022-02629-7
|
| 26 |
Wenyi Tang, Zhilin Gu, Jiuqi Guo, Mingzhi Lin, Hongqian Tao, Dalin Jia, Pengyu Jia. Activins and Inhibins in Cardiovascular Pathophysiology. Biomolecules 2024; 14(11): 1462 doi: 10.3390/biom14111462
|
| 27 |
Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong. The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma. Clinical and Molecular Hepatology 2020; 26(4): 492 doi: 10.3350/cmh.2020.0005
|
| 28 |
Pei-Wen Wang, Tung-Yi Lin, Pei-Ming Yang, Chau-Ting Yeh, Tai-Long Pan. Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(18): 10777 doi: 10.3390/ijms231810777
|
| 29 |
Bassem Refaat, Adel Galal El-Shemi, Ahmed Mohamed Ashshi, Adnan AlZanbagi. Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report. Gastroenterology Research and Practice 2014; 2014: 1 doi: 10.1155/2014/628683
|
| 30 |
Emine Sahin, Julia Münzker, Michael Grusch. Encyclopedia of Cancer. 2014; : 1 doi: 10.1007/978-3-642-27841-9_7169-9
|
| 31 |
Deng-Yong Zhang, Jia-Sheng Lei, Wan-Liang Sun, Dong-Dong Wang, Zheng Lu. Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma. Chinese Medical Journal 2020; 133(15): 1798 doi: 10.1097/CM9.0000000000000847
|
| 32 |
Hidekazu Ooe, Qijie Chen, Junko Kon, Kazunori Sasaki, Hiroyuki Miyoshi, Norihisa Ichinohe, Naoki Tanimizu, Toshihiro Mitaka. Proliferation of rat small hepatocytes requires follistatin expression. Journal of Cellular Physiology 2012; 227(6): 2363 doi: 10.1002/jcp.22971
|
| 33 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3127 doi: 10.1007/978-3-319-26956-6_172
|
| 34 |
Grigorios Panagiotou, Wael Ghaly, Jagriti Upadhyay, Kalliopi Pazaitou-Panayiotou, Christos S Mantzoros. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. The Journal of Clinical Endocrinology & Metabolism 2021; 106(5): e2137 doi: 10.1210/clinem/dgab041
|